Your session is about to expire
← Back to Search
Virtual Reality Medical Training for Emergency Training
Study Summary
This trial uses new tech to virtually simulate medical training scenarios, helping post-grad trainees learn & improve patient outcomes without physical presence.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I do not want to participate in the study.
- Group 1: Group A: HoloSIM (intervention)
- Group 2: Group B: Mannequin (control)
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there any available spots left in this trial for participants?
"Reports on clinicaltrials.gov reveal that this trial is not currently recruiting patients; the initial posting was made March 1, 2023 with its last update being February 6th of that same year. Despite this, there are 219 other trials actively enrolling participants at present."
Does this research accept participants aged eighty or more?
"The ideal applicants for this medical trial must be between the ages of 20 to 100. Additionally, there exist 49 clinical trials catering to those below 18 years old and a further 178 studies specifically designed for senior citizens over 65."
Are the criteria I meet compatible with this clinical trial?
"For this research, 40 volunteers between the ages 20 and 100 with urgent medical issues are being admitted. To meet eligibility requirements, these recruits must be Internal Medicine, Emergency Medicine, Anesthesiology or Critical Care Medicine Residents/Fellows from Sunnybrook Health Sciences Centre."
Share this study with friends
Copy Link
Messenger